263 related articles for article (PubMed ID: 33693944)
1. Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
Chatzimavridou-Grigoriadou V; Al-Othman S; Brabant G; Kyriacou A; King J; Blackhall F; Trainer PJ; Higham CE
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4766-e4775. PubMed ID: 33693944
[TBL] [Abstract][Full Text] [Related]
2. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
Han SW; Yi JH; Kang KP; Kim HY; Kim SW; Choi HY; Ha SK; Kim GH; Kim YW; Jeong KH; Shin SK; Kim HJ
J Korean Med Sci; 2018 Apr; 33(15):e112. PubMed ID: 29629516
[TBL] [Abstract][Full Text] [Related]
4. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
5. Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis.
Indirli R; Ferreira de Carvalho J; Cremaschi A; Mantovani B; Sala E; Serban AL; Locatelli M; Bertani G; Carosi G; Fiore G; Tariciotti L; Arosio M; Mantovani G; Ferrante E
Front Endocrinol (Lausanne); 2021; 12():689887. PubMed ID: 34108941
[TBL] [Abstract][Full Text] [Related]
6. Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.
Arecco A; Demontis D; Della Sala L; Musso N; Gay S; Boschetti M; Ferone D; Gatto F
Front Endocrinol (Lausanne); 2023; 14():1309657. PubMed ID: 38288467
[TBL] [Abstract][Full Text] [Related]
7. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
Estilo A; McCormick L; Rahman M
Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
[TBL] [Abstract][Full Text] [Related]
8. Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer.
Bilgetekin I; Erturk I; Basal FB; Karacin C; Karadurmus N; Oksuzoglu B; Demirci U
Int Urol Nephrol; 2021 Feb; 53(2):301-307. PubMed ID: 32869173
[TBL] [Abstract][Full Text] [Related]
9. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis.
Humayun MA; Cranston IC
BMC Endocr Disord; 2017 Nov; 17(1):69. PubMed ID: 29110656
[TBL] [Abstract][Full Text] [Related]
10. Urea in cancer patients with chronic SIAD-induced hyponatremia: Old drug, new evidence.
Nervo A; D'Angelo V; Rosso D; Castellana E; Cattel F; Arvat E; Grossi E
Clin Endocrinol (Oxf); 2019 Jun; 90(6):842-848. PubMed ID: 30868608
[TBL] [Abstract][Full Text] [Related]
11. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
Chen S; Zhao JJ; Tong NW; Guo XH; Qiu MC; Yang GY; Liu ZM; Ma JH; Zhang ZW; Gu F
J Clin Pharmacol; 2014 Dec; 54(12):1362-7. PubMed ID: 24906029
[TBL] [Abstract][Full Text] [Related]
13. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
Vaghasiya RP; DeVita MV; Michelis MF
Int Urol Nephrol; 2012 Jun; 44(3):865-71. PubMed ID: 21607553
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
Rajendran R; Grossman AB; Kar P
Endocr J; 2012; 59(10):903-9. PubMed ID: 22785335
[TBL] [Abstract][Full Text] [Related]
15. Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey.
Sağ S; Aydın Kaderli A; Yıldız A; Gül BC; Özdemir B; Baran İ; Güllülü S; Aydınlar A; Çavuşoğlu Y
Turk Kardiyol Dern Ars; 2017 Jul; 45(5):415-425. PubMed ID: 28694395
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study on tolvaptan prescription in clinical practice in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) using the Japanese claims database.
Hagiwara D; Matsukawa M; Tasaki J; Nakamura Y; Arima H
Endocr J; 2023 Dec; 70(12):1195-1205. PubMed ID: 37914256
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Oral Tolvaptan Therapy in Hospitalized Cirrhotic Patients with Hyponatremia.
Garg R; Kaur K; Aggarwal S; Singh N
J Assoc Physicians India; 2018 Dec; 66(12):49-52. PubMed ID: 31315326
[TBL] [Abstract][Full Text] [Related]
18. Acute hyponatremia after aneurysmal subarachnoid hemorrhage: Frequency, treatment, and outcome.
Kieninger M; Kerscher C; Bründl E; Bele S; Proescholdt M; Zeman F; Graf B; Schmidt NO; Schebesch KM
J Clin Neurosci; 2021 Jun; 88():237-242. PubMed ID: 33992191
[TBL] [Abstract][Full Text] [Related]
19. Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
Kai K; Tominaga N; Koitabashi K; Ichikawa D; Shibagaki Y
CEN Case Rep; 2019 May; 8(2):112-118. PubMed ID: 30637666
[TBL] [Abstract][Full Text] [Related]
20. Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety.
Salahudeen AK; Ali N; George M; Lahoti A; Palla S
Cancer; 2014 Mar; 120(5):744-51. PubMed ID: 24895288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]